gvtcx

NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib

NHS England Published 11 Mar 2021 Contracts Finder

key details

Value£17,300,000
Statuscomplete
Category (CPV) 33600000
Deadline8 Dec 2020
Contract start15 Jan 2021
Contract end31 Oct 2021
Procedureopen
SME suitableYes
OCIDocds-b5fd17-ea867963-6cec-487b-a927-215e4329a166

Awards (10)

This procurement was awarded to 10 suppliers. Values shown are per-award; the notice total is £17,300,000.

SupplierValueDateStatus
Accord-UK Ltd shared £17,300,000 4 Jan 2021 active
AstraZeneca shared £17,300,000 4 Jan 2021 active
Cipla (EU) Ltd shared £17,300,000 4 Jan 2021 active
Dr.Reddy's Laboratories (UK) Limited shared £17,300,000 4 Jan 2021 active
Janssen-Cilag Ltd shared £17,300,000 4 Jan 2021 active
Novartis Pharmaceuticals UK Ltd shared £17,300,000 4 Jan 2021 active
Sandoz Ltd shared £17,300,000 4 Jan 2021 active
Teva UK Limited shared £17,300,000 4 Jan 2021 active
Thornton and Ross Ltd shared £17,300,000 4 Jan 2021 active
Zentiva Pharma UK Ltd shared £17,300,000 4 Jan 2021 active

description

NHS National Pharmaceuticals - Fulvestrant, Darunavir and Imatinib

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

2 notices published against this procurement.

PublishedTypeRegimeNotice
25 Nov 2020 Tender (tender) · feafa02a-65aa-40f7-b5ca-10669b25b549-395873
11 Mar 2021 Award (award) · 55758111-02de-455e-9d99-0de2dd7cd0d3-419535

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.